Monograph: Ranibizumab (EENT)

Ranibizumab (EENT)

Die Inhalte stehen nur registrierten Benutzern zur Verfügung.

Sie sind zum ersten mal hier und möchten die Datenbank 10-Tage kostenlos testen, dann registrieren Sie sich einmalig. Nach der Registrierung melden Sie sich mit Ihrem Benutzernamen und Passwort an.

Sie sind bereits bei DrugBase registriert und möchten diese Datenbank 10-Tage kostenlos und unverbindlich testen? Dann melden Sie sich mit Ihren Zugangsdaten an und wählen Sie anschließend die Datenbank, die Sie testen möchten.

Full Title

Ranibizumab (EENT)

Generic Name

Ranibizumab

Chemical Name

...

Synonym

...

Classification

CAS Number

...

Introduction

Introduction

...

...

Description

...

...

Uses

Uses

...

Neovascular Age-related Macular Degeneration

...

Macular Edema Following Retinal Vein Occlusion

...

Diabetic Macular Edema

...

Diabetic Retinopathy in Patients with Diabetic Macular Edema

...

...

Dosage and Administration

Dosage and Administration

...

Administration

...

Dosage

...

Neovascular Age-related Macular Degeneration

...

Macular Edema Following Retinal Vein Occlusion

...

Diabetic Macular Edema

...

Diabetic Retinopathy in Patients with Diabetic Macular Edema

...

Special Populations

...

...

Cautions

Cautions

...

Contraindications

...

Warnings/Precautions

...

Endophthalmitis and Other Serious Ocular Effects

...

Increased Intraocular Pressure

...

Thromboembolic Events

...

Fatal Events

...

Immunogenicity

...

Specific Populations

...

Pregnancy

...

Lactation

...

Pediatric Use

...

Geriatric Use

...

Renal Impairment

...

Common Adverse Effects

...

...

Drug Interactions

Drug Interactions

...

Photodynamic Therapy with Verteporfin

...

...

Advice to Patients

Advice to Patients

...

...

Preparations

Preparations

...

Ranibizumab (Recombinant)

...

...

Common general statement Elements

Additional Information

...

...

References

References

...

...

Copyright

AHFS® Drug Information. © Copyright, 1959-2020, Selected Revisions June 30, 2016. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.

Quelle

AHFS Drug Information